EP4217398
LYFJATENGD MÓTEFNI GEGN C-MET
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.4.2022EP published:
24.9.2025EP application number:
22796992.0
EP translation filed:
3.11.2025Grant published:
15.12.2025EPO information:
European Patent Register
Max expiry date:
28.4.2042Expiry date:
28.4.2026
Title in English:
ANTI-C-MET ANTIBODY DRUG CONJUGATESLanguage of the patent:
English
Timeline
Today
29.4.2022EP application
24.9.2025EP Publication
3.11.2025Translation submitted
15.12.2025Registration published
28.4.2026Expires
Owner
Name:
AbbVie Manufacturing Management Unlimited CompanyAddress:
70 Sir John Rogerson's Quay, Dublin, D02 R296, IE
Inventor
Name:
PHILLIPS, Andrew C.Address:
Libertyville, Illinois 60048, US
Name:
REILLY, Regina M.Address:
Libertyville, Illinois 60048, US
Name:
DOHERTY, George A.Address:
Libertyville, Illinois 60048, US
Name:
JI, ChengAddress:
Buffalo Grove, Illinois 60089, US
Name:
BRUNCKO, MilanAddress:
Green Oaks, Illinois 60048, US
Name:
BOGHAERT, Erwin R.Address:
Pleasant Prairie, Wisconsin 53158, US
Name:
ANDERSON, MarkAddress:
Grayslake, Illinois 60030, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
202163181963 PDate:
29.4.2021Country:
US
Classification
Categories:
A61K 47/68, C07K 16/28, C07D 491/22, C07D 317/44, C07D 317/70, A61P 35/00